Artelo biosciences, inc. (ARTL)
Income statement / Yearly
Aug'19Aug'18Aug'17Aug'16Aug'15Aug'14
Revenue

-

-

-

0

0

0

Operating Expenses Abstract
General and administrative

952

508

110

0

0

4

Professional fees

1,164

585

121

28

14

11

Research and Development Expense

1,091

1,249

-

-

-

-

Depreciation

0

0

-

-

-

-

Operating Expenses

3,209

2,343

232

29

15

15

Operating Income (Loss)

-3,209

-2,343

-232

-29

-15

-15

Other Expense, Nonoperating [Abstract]
Total other expense

31

-

-

-

-

-

Represents the change in fair value for the period of warrant derivative liability.

1,006

-

-

-

-

-

Interest expense

-

-

2

-

-

-

Total other income

1,037

-

-2

-

-

-

Income Tax Expense (Benefit)

0

0

0

0

0

0

Net Income (Loss) Attributable to Parent

-2,172

-2,343

-234

-29

-15

-15

Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax

2

-12

0

-

-

-

Foreign currency translation adjustments

2

-12

0

-

-

-

Total comprehensive loss

-2,169

-2,356

-234

-

-

-

Earnings Per Share, Basic

-1.00

-1.84

-

-

-

-

Earnings Per Share, Diluted

-1.46

-1.84

-

-

-

-

Weighted Average Number of Shares Outstanding, Basic

2,172

1,277

-

-

-

-

Weighted Average Number of Shares Outstanding, Diluted

2,172

1,277

-

-

-

-

Basic and Diluted Loss per Common Share (in dollars per share)

-

-

-0.03

0.00

0.00

0.00

Basic and Diluted Weighted Average Common Shares Outstanding (in shares)

-

-

8,732

7,640

6,406

3,073